Plain-English summary
Court vacates Fifth Circuit ruling and remands in dispute over FDA review of new tobacco products
The Court unanimously vacated the Fifth Circuit’s judgment and remanded. The case involved whether the FDA properly applied statutory standards when denying premarket authorization for new tobacco products. The decision narrows the appellate court’s review and sends the matter back for further proceedings.
Why this matters
The ruling clarifies how courts should review FDA decisions about whether new tobacco products can be sold, affecting how readily products can enter the market and how much deference courts must give the agency. That affects public-health regulation, industry business plans, and availability of new nicotine products.
Who may feel it
- Tobacco and vaping product manufacturers and distributors
- Public health and medical organizations
- State and local regulators enforcing tobacco laws
- Consumers of tobacco and nicotine products
Key questions
- What legal standard should courts use when reviewing FDA denials of applications to market new tobacco products under the Family Smoking Prevention and Tobacco Control Act?
- Did the Fifth Circuit apply the correct scope of review to the FDA’s denial decisions?